VC firm SR One completes GSK spin-out, raising $500m
Euro Falls Against Dollar on Risk-Off Sentiment, Rallies on US Jobs Data
Even With A Vaccine, Strategists Aren't Bullish On Europe
Pound Slides As EU Leaders Push To Start Brexit Contingency Planning
COVID-19 testing facilities open at Dublin Airport
Timidity returns to the stock markets amid the accelerating pandemic
Scoop: SR One crew completes a complicated spinout from GlaxoSmithKline. And now they have a $500M fund to invest on their own
Broad commodity ETFs prepare for Covid-19 shake-up
BioNTech says vaccine approval possible in mid-December under ideal conditions
Analysis: Can first Covid-19 vaccines bring herd immunity? Experts have doubts
Weekly investment update – Vaccine optimism reflates markets
Global daily coronavirus deaths cross record – Reuters tally
Climate crisis: how museums could inspire radical action
CureVac To Boost Covid-19 Vaccine Production To 300M Doses In 2021
COVID-19: Helping to support momentum on antimicrobial innovation
Sanofi Wins FDA Priority Review For Enzyme Therapy; Street Bullish
Currency markets drifting
Could a Brexit deal be possible by next week?
China's Xi: World Economy In Worst Recession Since Great Depression
Is There Really A China Economic Miracle?
Kids mount a COVID-19 immune response without detection of the SARSCoV- 2 virus
Increasing patient engagement with UK clinical trials
Covid-19 roundup: EU begins reviewing Moderna vaccine; CureVac and EU agree to 405M-dose deal
Promising results from in vitro combination therapy against COVID-19
Blain: The World Changed...
Stop Worrying About The US Government National Deficits
Covid-19 roundup: CureVac and EU agree to 405M-dose deal; WHO warns that vaccine news is no panacea
Global Stocks Slide As Attention Turns To Global Economic Shutdowns
Macro Briefing: 17 November 2020
Europe's Green Deal Is Bad News For US LNG